Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review

BACKGROUND: We conducted a systematic review examining the cost effectiveness of a 3-month course of isoniazid and rifapentine, known as 3HP, given by directly observed treatment, compared to 9 months of isoniazid that is directly observed or self-administered, for latent tuberculosis infection. 3HP...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Wendy A., Brethour, Kaitlyn, D’Silva, Olivia, Chaisson, Richard E., Zwerling, Alice A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727859/
https://www.ncbi.nlm.nih.gov/pubmed/36476206
http://dx.doi.org/10.1186/s12889-022-14766-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727859/
https://www.ncbi.nlm.nih.gov/pubmed/36476206
http://dx.doi.org/10.1186/s12889-022-14766-6

Ejemplares similares